Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody

· Shanghai CP Guojian Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody, covering 2011-10-26 to 2011-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma [Phase 3]

See pricing